FDA Label for As03
View Indications, Usage & Precautions
As03 Product Label
The following document was submitted to the FDA by the labeler of this product Glaxosmithkline Biologicals Sa. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Other
Health Care Professional and Patient Fact Sheets are not available at this time.
Principal Display Panel
NDC 58160-855-19
AS03 Adjuvant Component
NOTICE: NOT TO BE USED ALONE
One vial of AS03 Adjuvant Component and one vial of Antigen Component MUST BE COMBINED BEFORE USE.
10 Vials of AS03 Adjuvant Component
One vial of AS03 Adjuvant Component must be added to one vial of Antigen Component to form ten 0.5-mL doses of vaccine.
Rx only
Rev. 11/20
504407
* Please review the disclaimer below.
